South Korea
· Delayed Price · Currency is KRW UBcare. Statistics
Total Valuation
UBcare. has a market cap or net worth of KRW 175.06 billion. The enterprise value is 173.82 billion.
| Market Cap | 175.06B |
| Enterprise Value | 173.82B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UBcare. has 50.74 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.74M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.88% |
| Float | 23.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.03 |
| PB Ratio | 1.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.83, with an EV/FCF ratio of -83.22.
| EV / Earnings | -253.62 |
| EV / Sales | 1.02 |
| EV / EBITDA | 26.83 |
| EV / EBIT | n/a |
| EV / FCF | -83.22 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.74 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 2.32 |
| Debt / FCF | -9.22 |
| Interest Coverage | 1.52 |
Financial Efficiency
Return on equity (ROE) is -0.33% and return on invested capital (ROIC) is 0.85%.
| Return on Equity (ROE) | -0.33% |
| Return on Assets (ROA) | 0.69% |
| Return on Capital (ROIC) | 0.85% |
| Revenue Per Employee | 524.85M |
| Profits Per Employee | -2.11M |
| Employee Count | 325 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 8.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.60% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.60% |
| 50-Day Moving Average | 3,940.20 |
| 200-Day Moving Average | 4,673.20 |
| Relative Strength Index (RSI) | 35.43 |
| Average Volume (20 Days) | 1,797,389 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UBcare. had revenue of KRW 170.58 billion and -685.33 million in losses. Loss per share was -13.42.
| Revenue | 170.58B |
| Gross Profit | 85.47B |
| Operating Income | 1.76B |
| Pretax Income | 859.54M |
| Net Income | -685.33M |
| EBITDA | 8.28B |
| EBIT | 1.76B |
| Loss Per Share | -13.42 |
Balance Sheet
The company has 29.06 billion in cash and 19.26 billion in debt, giving a net cash position of 9.80 billion or 193.20 per share.
| Cash & Cash Equivalents | 29.06B |
| Total Debt | 19.26B |
| Net Cash | 9.80B |
| Net Cash Per Share | 193.20 |
| Equity (Book Value) | 109.02B |
| Book Value Per Share | 1,979.76 |
| Working Capital | 26.56B |
Cash Flow
In the last 12 months, operating cash flow was 89.86 million and capital expenditures -2.18 billion, giving a free cash flow of -2.09 billion.
| Operating Cash Flow | 89.86M |
| Capital Expenditures | -2.18B |
| Free Cash Flow | -2.09B |
| FCF Per Share | -41.16 |
Margins
Gross margin is 50.11%, with operating and profit margins of 1.03% and -0.40%.
| Gross Margin | 50.11% |
| Operating Margin | 1.03% |
| Pretax Margin | 0.50% |
| Profit Margin | -0.40% |
| EBITDA Margin | 4.86% |
| EBIT Margin | 1.03% |
| FCF Margin | -1.22% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | 60.00 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | 0.71% |
| Earnings Yield | -0.39% |
| FCF Yield | -1.19% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UBcare. has an Altman Z-Score of 4.35.
| Altman Z-Score | 4.35 |
| Piotroski F-Score | n/a |